Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-01-04 @ 2:46 AM
Study NCT ID:
NCT01685359
Status:
COMPLETED
Last Update Posted:
2022-10-28
First Post:
2012-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant
Sponsor:
Azidus Brasil
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EPOBLA0612IV-I2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None